eMedicine Specialties > Emergency Medicine > Environmental

Hydrofluoric Acid Burns

Author: Garry Wilkes, MBBS, FACEM, Director of Emergency Medicine, Bunbury Hospital, Western Australia; Medical Consultant, St John Ambulance, WA Ambulance Service; Adjunct Associate Professor, Edith Cowan University; Clinical Associate Professor, Rural Clinical School, University of Western Australia
Contributor Information and Disclosures

Updated: Jan 28, 2010

Introduction

Background

Hydrofluoric (HF) acid, one of the strongest inorganic acids, is used mainly for industrial purposes (eg, glass etching, metal cleaning, electronics manufacturing). Hydrofluoric acid also may be found in home rust removers. Exposure usually is unintentional and often is due to inadequate use of protective measures.

Hydrofluoric acid burns are a unique clinical entity. Dilute solutions deeply penetrate before dissociating, thus causing delayed injury and symptoms. Burns to the fingers and nail beds may leave the overlying nails intact, and pain may be severe with little surface abnormality.

Severe burns occur after exposure of concentrated (ie, 50% or stronger solution) hydrofluoric acid to 1% or more body surface area (BSA), exposure to hydrofluoric acid of any concentration to 5% or more BSA, or inhalation of hydrofluoric acid fumes from a 60% or stronger solution. The vast majority of cases involve only small areas of exposure, usually on the digits.

A unique feature of HF exposure is its ability to cause significant systemic toxicity due to fluoride poisoning.

Pathophysiology

The 2 mechanisms that cause tissue damage are corrosive burn from the free hydrogen ions and chemical burn from tissue penetration of the fluoride ions.

Fluoride ions penetrate and form insoluble salts with calcium and magnesium. Soluble salts also are formed with other cations but dissociate rapidly. Consequently, fluoride ions release, and further tissue destruction occurs.

Systemic toxicity occurs secondary to depletion of total body stores of calcium and magnesium, resulting in enzymatic and cellular dysfunction, and ultimately in cell death. Majority of deaths are resulting from cardiac arrhythmias that were precipitated by hypocalcaemia and consequent hyperkalemia.1

Frequency

United States

More than 1000 cases of hydrofluoric acid exposure are reported annually. Actual incidence rate is unknown.

In a review of 15 years' experience with hydrofluoric acid burns at one center, hydrofluoric acid burns accounted for 35 (17%) patients out of 205 who were admitted for chemical burns; all of these patients were men.2

Mortality/Morbidity

  • Local effects of hydrofluoric acid burns include tissue destruction and necrosis. Burns may involve underlying bone.
  • Systemic fluoride ion poisoning from severe burns may be associated with hypocalcemia, hyperkalemia, hypomagnesemia, and sudden death.
  • Deaths have been reported from concentrated acid burns to as little as 2.5% BSA.

Sex

Males are affected more commonly by hydrofluoric acid burns, which reflects occupational patterns.

Age

The majority of hydrofluoric acid exposures occurs in adults.

Clinical

History

  • Time of exposure to onset of symptoms is related to the concentration of the hydrofluoric acid:
    • Solutions of 14.5% and higher concentrations immediately produce symptoms.
    • Solutions of 12% may take up to an hour to produce symptoms.
    • Solutions of less than 7% may take several hours before onset of symptoms, resulting in delayed presentation, deeper penetration of the undissociated HF acid, and a more severe burn.
    • Concentrated solutions cause immediate pain and produce surface burns similar to those produced by other common acids (eg, erythema, blistering, necrosis).
    • Pain typically is described as deep, burning, or throbbing.
    • Pain often is disproportionate to apparent skin involvement.
  • Obtain history of potential exposure to cleaning solutions within the last 24 hours, to include the following:
    • Duration and type of exposure
      • Skin
      • Ophthalmic
      • Gastrointestinal (vomiting, abdominal pain)
      • Pulmonary (throat burning, dyspnea)
    • Concentration of acid
    • Use of protective measures
    • Other agents in the solution
    • Symptoms of hypocalcemia
      • Tetany
      • Chvostek sign
      • Trousseau sign
    • Cardiac arrhythmias
  • Additionally, obtain history of medications and intercurrent illness that predispose patient to hypocalcemia or hypomagnesemia.

Physical

  • Weaker solutions penetrate before dissociating.
  • Surface involvement in these cases is minimal and may be absent.
  • Three categories of appearance include the following:
    • Grade 1 - A white burn mark and/or erythema and pain; a grade 1 burn is shown in the photo below

    • Grade 1 hydrofluoric (HF) acid burns of the finge...

      Grade 1 hydrofluoric (HF) acid burns of the fingertips. The patient has severe pain (maximum middle digit) with only minimal redness of the nail beds.

      Grade 1 hydrofluoric (HF) acid burns of the finge...

      Grade 1 hydrofluoric (HF) acid burns of the fingertips. The patient has severe pain (maximum middle digit) with only minimal redness of the nail beds.


      {{mediacaption:773375_1}}  
    • Grade 2 - A white burn mark and/or erythema and pain, plus edema and blistering
    • Grade 3 - A white burn mark and/or erythema and pain, edema, and blistering, plus necrosis; a grade 3 burn is shown in the photo below

    • Grade 3 hydrofluoric (HF) acid burns of the finge...

      Grade 3 hydrofluoric (HF) acid burns of the fingertips. Note how the nailbed and tip of the fingers have severely been injured, but the nails show no damage.

      Grade 3 hydrofluoric (HF) acid burns of the finge...

      Grade 3 hydrofluoric (HF) acid burns of the fingertips. Note how the nailbed and tip of the fingers have severely been injured, but the nails show no damage.


      {{mediacaption:773376_2}}  
  • Patients with inhalation burns may develop acute lung injury presenting with the following:
    • Hypoxemia
    • Stridor
    • Wheezing
    • Rhonchi
  • Ocular burns may present with severe pain.

More on Hydrofluoric Acid Burns

Overview: Hydrofluoric Acid Burns
Differential Diagnoses & Workup: Hydrofluoric Acid Burns
Treatment & Medication: Hydrofluoric Acid Burns
Follow-up: Hydrofluoric Acid Burns
Multimedia: Hydrofluoric Acid Burns
References

References

  1. McIvor ME. Delayed fatal hyperkalemia in a patient with acute fluoride intoxication. Ann Emerg Med. Oct 1987;16(10):1165-7. [Medline].

  2. Stuke LE, Arnoldo BD, Hunt JL, Purdue GF. Hydrofluoric acid burns: a 15-year experience. J Burn Care Res. Nov-Dec 2008;29(6):893-6. [Medline].

  3. Dalamaga M, Karmaniolas K, Nikolaidou A, Papadavid E. Hypocalcemia, hypomagnesemia, and hypokalemia following hydrofluoric acid chemical injury. J Burn Care Res. May-Jun 2008;29(3):541-3. [Medline].

  4. Bertolini JC. Hydrofluoric acid: a review of toxicity. J Emerg Med. Mar-Apr 1992;10(2):163-8. [Medline].

  5. Chan BS, Duggin GG. Survival after a massive hydrofluoric acid ingestion. J Toxicol Clin Toxicol. 1997;35(3):307-9. [Medline].

  6. Dunn BJ, MacKinnon MA, Knowlden NF, et al. Topical treatments for hydrofluoric acid dermal burns. Further assessment of efficacy using an experimental piq model. J Occup Environ Med. May 1996;38(5):507-14. [Medline].

  7. Dunser MW, Ohlbauer M, Rieder J, Zimmermann I, Ruatti H, Schwabegger AH, et al. Critical care management of major hydrofluoric acid burns: a case report, review of the literature, and recommendations for therapy. Burns. Jun 2004;30(4):391-8. [Medline].

  8. Graudins A, Burns MJ, Aaron CK. Regional intravenous infusion of calcium gluconate for hydrofluoric acid burns of the upper extremity. Ann Emerg Med. Nov 1997;30(5):604-7. [Medline].

  9. Greco RJ, Hartford CE, Haith LR Jr, et al. Hydrofluoric acid-induced hypocalcemia. J Trauma. Nov 1988;28(11):1593-6. [Medline].

  10. Hatzifotis M, Williams A, Muller M, Pegg S. Hydrofluoric acid burns. Burns. Mar 2004;30(2):156-9. [Medline].

  11. Henry JA, Hla KK. Intravenous regional calcium gluconate perfusion for hydrofluoric acid burns. J Toxicol Clin Toxicol. 1992;30(2):203-7. [Medline].

  12. Kono K, Watanabe T, Dote T, et al. Successful treatments of lung injury and skin burn due to hydrofluoric acid exposure. Int Arch Occup Environ Health. Jun 2000;73 Suppl:S93-7. [Medline].

  13. Mayer TG, Gross PL. Fatal systemic fluorosis due to hydrofluoric acid burns. Ann Emerg Med. Feb 1985;14(2):149-53. [Medline].

  14. McIvor ME, Cummings CE, Mower MM, et al. Sudden cardiac death from acute fluoride intoxication: the role of potassium. Ann Emerg Med. Jul 1987;16(7):777-81. [Medline].

  15. Nguyen LT, Mohr WJ 3rd, Ahrenholz DH, Solem LD. Treatment of hydrofluoric acid burn to the face by carotid artery infusion of calcium gluconate. J Burn Care Rehabil. Sep-Oct 2004;25(5):421-4. [Medline].

  16. Ohata U, Hara H, Suzuki H. 7 cases of hydrofluoric acid burn in which calcium gluconate was effective for relief of severe pain. Contact Dermatitis. Mar 2005;52(3):133-7. [Medline].

  17. Roblin I, Urban M, Flicoteau D, Martin C, Pradeau D. Topical treatment of experimental hydrofluoric acid skin burns by 2.5% calcium gluconate. J Burn Care Res. Nov-Dec 2006;27(6):889-94. [Medline].

  18. Ryan JM, McCarthy GM, Plunkett PK. Regional intravenous calcium--an effective method of treating hydrofluoric acid burns to limb peripheries. J Accid Emerg Med. Nov 1997;14(6):401-4. [Medline].

  19. Shewmake SW, Anderson BG. Hydrofluoric acid burns. A report of a case and review of the literature. Arch Dermatol. May 1979;115(5):593-6. [Medline].

  20. Soderberg K, Kuusinen P, Mathieu L, Hall AH. An improved method for emergent decontamination of ocular and dermal hydrofluoric acid splashes. Vet Hum Toxicol. Aug 2004;46(4):216-8. [Medline].

  21. Vance MV, Curry SC, Kunkel DB, et al. Digital hydrofluoric acid burns: treatment with intraarterial calcium infusion. Ann Emerg Med. Aug 1986;15(8):890-6. [Medline].

  22. Velvart J. Arterial perfusion for hydrofluoric acid burns. Hum Toxicol. Apr 1983;2(2):233-8. [Medline].

  23. Wilkes GJ. Intravenous regional calcium gluconate for hydrofluoric acid burns of the digits. Emerg Med (Aust). 1993;5:155-8.

  24. Wilkes GJ, Morel DG. Hydrofluoric acid burns of the hands. In: Abstracts of the 6th International Conference on Emergency Medicine. Sydney. 1996.

Further Reading

Keywords

hydrofluoric acid burn causes, HF acid burns, HF acid exposure, hydrofluoric acid burn treatment, hydrofluoric acid exposure, hydrofluoric acid burns

Contributor Information and Disclosures

Author

Garry Wilkes, MBBS, FACEM, Director of Emergency Medicine, Bunbury Hospital, Western Australia; Medical Consultant, St John Ambulance, WA Ambulance Service; Adjunct Associate Professor, Edith Cowan University; Clinical Associate Professor, Rural Clinical School, University of Western Australia
Disclosure: Nothing to disclose.

Medical Editor

Edward A Michelson, MD, Program Director, Associate Professor, Department of Emergency Medicine, University Hospital Health Systems in Cleveland
Edward A Michelson, MD is a member of the following medical societies: American College of Emergency Physicians, National Association of EMS Physicians, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

John T VanDeVoort, PharmD, Regional Director of Pharmacy, Sacred Heart & St. Joseph's Hospitals
John T VanDeVoort, PharmD is a member of the following medical societies: American Society of Health-System Pharmacists
Disclosure: Nothing to disclose.

Managing Editor

Richard H Sinert, DO, Associate Professor of Emergency Medicine, Clinical Assistant Professor of Medicine, Research Director, State University of New York College of Medicine; Consulting Staff, Department of Emergency Medicine, Kings County Hospital Center
Richard H Sinert, DO is a member of the following medical societies: American College of Physicians and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Asim Tarabar, MD, Assistant Professor, Director, Medical Toxicology, Department of Emergency Medicine, Yale University School of Medicine; Consulting Staff, Department of Emergency Medicine, Yale-New Haven Hospital
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.